secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ginkgo Bioworks Holdings, Inc. (DNA)
CIK:        0001830214
Form:       8-K
Filed at:   2024-03-14T23:59:59+00:00
Accession:  0001628280-24-011216
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ginkgo Bioworks replaces auditor: EY declines reappointment, Deloitte hired
---------------------------------------------------------------------------

- EY notified Ginkgo on March 8, 2024 it would not stand for reappointment as auditor for fiscal 2024; no disagreement cited.
- Audit Committee appointed Deloitte & Touche as new independent auditor on March 13, 2024.
- EY's reports for FY 2022 and 2023 were unqualified; no adverse opinions or scope limitations.
- Material weaknesses in internal control over financial reporting were disclosed for both 2022 and 2023, as previously reported.
- No disagreements or reportable events (other than the material weaknesses) occurred during the relevant periods.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1830214/000162828024011216/0001628280-24-011216-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1830214/000162828024011216/dna-20240308.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-011216

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer